Literature DB >> 11231036

Effects of slow repetitive transcranial magnetic stimulation on heart rate variability according to power spectrum analysis.

T Yoshida1, A Yoshino, Y Kobayashi, M Inoue, K Kamakura, S Nomura.   

Abstract

We examined whether repetitive transcranial magnetic stimulation (rTMS) at a low rate could influence autonomic function, specially heart rate variability (HRV) by power spectrum analysis. We studied 16 healthy male volunteers as a stimulation group and 16 others as a sham group. The stimulation group received magnetic stimulations from a circular coil over Cz at a frequency of 0.2 Hz and an intensity presenting 90% of the motor threshold. Experiments in both groups included four daily sessions; at each, a train of 70 stimuli was delivered over 350 s. HRV of low-frequency power (LF) in a standing position and high-frequency power (HF) in a supine position were measured before and after each session. After stimulation, HF and LF powers were significantly increased. After sham stimulation, the power of HF but not that of LF significantly increased. Neither actual nor sham stimulation produced a long-term effect detectable on day 5. The finding of transiently increased LF power following actual but not sham stimulation suggests that rTMS may activate the sympathetic nervous system.

Mesh:

Year:  2001        PMID: 11231036     DOI: 10.1016/s0022-510x(00)00505-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Effects of prefrontal repetitive transcranial magnetic stimulation on the autonomic regulation of cardiovascular function.

Authors:  Giosué Gulli; Cantor Tarperi; Antonio Cevese; Michele Acler; Giuseppe Bongiovanni; Paolo Manganotti
Journal:  Exp Brain Res       Date:  2013-03-02       Impact factor: 1.972

2.  Sympathetic responses to repetitive trans-spinal magnetic stimulation.

Authors:  Roger J Paxton; Matthew P Malcolm; Sean A Newsom; Jennifer C Richards; Grant M Rynn; Christopher Bell
Journal:  Clin Auton Res       Date:  2010-11-27       Impact factor: 4.435

Review 3.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

Authors:  Simone Rossi; Mark Hallett; Paolo M Rossini; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708

4.  A systematic review of non-invasive brain stimulation therapies and cardiovascular risk: implications for the treatment of major depressive disorder.

Authors:  Leonardo Augusto Negreiros Parente Capela Sampaio; Renerio Fraguas; Paulo Andrade Lotufo; Isabela Martins Benseñor; André Russowsky Brunoni
Journal:  Front Psychiatry       Date:  2012-10-10       Impact factor: 4.157

5.  Plasma brain-derived neurotrophic factor and reverse dipping pattern of nocturnal blood pressure in patients with cardiovascular risk factors.

Authors:  Manabu Kadoya; Hidenori Koyama; Akinori Kanzaki; Masafumi Kurajoh; Miki Hatayama; Jun Shiraishi; Hirokazu Okazaki; Takuhito Shoji; Yuji Moriwaki; Tetsuya Yamamoto; Masaaki Inaba; Mitsuyoshi Namba
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

6.  Effects of weekly low-frequency rTMS on autonomic measures in children with autism spectrum disorder.

Authors:  Manuel Fernando Casanova; Marie K Hensley; Estate M Sokhadze; Ayman S El-Baz; Yao Wang; Xiaoli Li; Lonnie Sears
Journal:  Front Hum Neurosci       Date:  2014-10-21       Impact factor: 3.169

7.  Induced effects of transcranial magnetic stimulation on the autonomic nervous system and the cardiac rhythm.

Authors:  Mercedes Cabrerizo; Anastasio Cabrera; Juan O Perez; Jesus de la Rua; Niovi Rojas; Qi Zhou; Alberto Pinzon-Ardila; Sergio M Gonzalez-Arias; Malek Adjouadi
Journal:  ScientificWorldJournal       Date:  2014-07-17

Review 8.  Autonomic modulation of ventricular electrical activity: recent developments and clinical implications.

Authors:  Valerie Y H van Weperen; Marc A Vos; Olujimi A Ajijola
Journal:  Clin Auton Res       Date:  2021-09-30       Impact factor: 4.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.